Bimeda Griseofulvin Powder (microsize) For Oral Use In Horses
Recall announced August 24, 2018 by Bimeda, Inc, posted by the U.S. Food and Drug Administration (FDA). Reason: Griseofulvic Acid (specification is NMT 1.0%) and Single Unknown Impurity (specification is NMT 0.10%) results were above the specification limits, with results of 1.2% and 0.18%, respectively. It affects farm animals. The agency has closed this recall.
- Where sold
- CO, MO, OH, ID, MA, KS, FL
- Last updated
- November 19, 2026
Products included
- Griseofulvin Powder (microsize) For Oral Use In Horses, packaged in pre-printed pouches with Net Weight of 15 grams and Product No. 1GRI001 Contains 2.5 g Active Ingredient, Bimeda, Inc, One Tower Lane, Oakbrook Terrace, IL 60181. NDC: 61133-5434-1 (Lot 54340006, exp 09/2018;)
Read the official notice. Always compare the codes on your package with the official notice. It is the final word.
Has your pet used this product and seems unwell? Call your veterinarian or an emergency animal hospital now.
